What you need to know about the 18-week standard
What the standard promises
The NHS Constitution for England sets out a right to start consultant-led treatment within a maximum of 18 weeks of referral, unless you choose to wait longer or it is clinically appropriate that you do. [1] Alongside that right sits the operational standard used to measure the NHS: 92% of patients on an incomplete pathway should have been waiting no more than 18 weeks. [3]
The distinction matters. The right belongs to the individual patient and is about what should happen to you; the 92% standard is a system measure and allows for the reality that some pathways will run longer. Neither is a promise that a specific operation will take place on a specific date, and neither applies to every kind of care — urgent cancer pathways, for example, have their own separate standards.
How the clock works
The measurement is called the referral-to-treatment pathway. The clock starts when the hospital receives your referral — usually from your GP, sometimes from another service — and stops when your first definitive treatment begins. A first outpatient appointment does not stop the clock. Neither does a diagnostic test. If you are placed on a waiting list for surgery after a consultation, the clock is still running.
| Event | Effect on the clock |
|---|---|
| Hospital receives your referral | Clock starts |
| First outpatient appointment | Clock keeps running |
| Diagnostic tests and results | Clock keeps running |
| First definitive treatment begins | Clock stops |
| A decision that no treatment is needed | Clock stops |
| You choose to delay for personal reasons | The pathway may be adjusted |
Because the clock stops at treatment rather than at the appointment, the wait people experience and the wait that is reported can feel different. Someone seen quickly in clinic but waiting months for surgery is still counted as waiting, which is the correct way round, but it explains why a reassuringly prompt first appointment does not mean the pathway is on track.
How the NHS is performing
NHS England publishes referral-to-treatment figures monthly. For July 2026 data, published on 10 September 2026, 65.4% of incomplete pathways had been waiting up to 18 weeks, against the 92% operational standard. There were around 7.3 million pathways waiting, relating to roughly 6.2 million individual patients, and 1,985,434 new pathways started during the month. [3]
- Operational standard92%
- Actual performance65.4%
One patient can be on more than one pathway, which is why the number of pathways exceeds the number of patients. The gap between 65.4% and 92% is the practical context for everything else on this page: the right still exists, but the system is not currently delivering it at the rate the standard expects, and that is why the escalation routes below matter.
Adviser insight
“If someone is already on an NHS waiting list, the first thing I check is whether the treatment they are waiting for is the sort a new policy would cover at all — usually it is not, because it is already a known condition. What people often do not realise is that they can ask about being treated elsewhere in the NHS, where the wait may be shorter. Buying a policy to jump an existing queue almost never works, and it is better to know that before you pay a premium.”
What you can do if you are waiting
Step 1: Ask where you are on the pathway
The hospital can tell you your referral-to-treatment clock start date and your current status.
Step 2: Use your right to choose
You can usually choose a different provider at referral, and ask about alternatives if the wait is long.
Step 3: Ask the commissioner to investigate
If the standard cannot be met, you can ask for care to be arranged with another suitable provider.
Step 4: Escalate in writing
Contact the hospital’s patient advice and liaison service if the standard is not met.
Step 5: Keep your contact details current
Missed letters and calls are a common reason pathways stall.
The NHS publishes plain-English guidance on waiting times and on what to do when a wait becomes long. [2] That guidance has not been refreshed recently, so the monthly statistics rather than the guidance page are the better source for current performance. [3]
Where private cover fits
Private medical insurance does not shorten an NHS wait. It opens a separate route: for eligible conditions, treatment can be arranged privately without reference to the NHS queue. That is a real difference in access, and it is the main reason people buy cover, but it comes with the boundaries described in what private health insurance covers — new, acute conditions, subject to underwriting and to the excess you have chosen.
Using the NHS route and the private route
What works well
- NHS: free at the point of use, with a right to treatment within 18 weeks and no medical underwriting
- NHS: covers emergencies, chronic conditions and maternity, which policies generally do not
- Private: access for eligible conditions without joining the NHS queue
- Private: many policies pay a cash benefit if you choose NHS treatment instead of claiming
What to watch
- NHS: performance is currently well below the 92% standard
- NHS: the clock stops at treatment, so a quick first appointment is not the whole story
- Private: a condition you are already waiting for is likely to be pre-existing and excluded
- Private: cover is only as wide as the wording, the hospital list and the limits allow
A point worth being explicit about: if you are already on an NHS waiting list for a condition, buying a policy now will not normally cover that condition, because it pre-dates the policy. Cover bought today is for what happens next, not for what you are already waiting on. Anyone selling it to you must be authorised, and you can check that on the Financial Services Register. [4] If something goes wrong with a policy, the Financial Ombudsman Service can review it. [5]
Why the private market matters to NHS waits
Demand for private treatment has risen alongside NHS waits. Insurers covered 6.5 million people in 2024 and paid a record £4 billion in claims, up from £3.57 billion in 2023, with workplace schemes accounting for much of the growth. [6] Information about what private hospitals and consultants actually do is published by the Private Healthcare Information Network, which is the right place to look if you are comparing providers rather than policies. [7]
What the standard means in practice
The 18-week standard is a promise about the system, not a personal guarantee, and that distinction matters when you are the one waiting. It measures the share of pathways completed within the threshold, so a service can meet the standard overall while individual patients wait far longer, and it can miss the standard while treating urgent cases quickly. Suspected cancer and urgent referrals run on separate, shorter standards, and clinical priority always overrides the queue.
If your wait is becoming difficult, there are steps worth taking before you consider paying. Ask the hospital where you are on the pathway and whether the clock has been stopped or restarted. Ask your GP practice to check whether the referral has been received and accepted. Ask whether another provider in the region has a shorter wait, since patients in England generally have a legal right to choose. Keep a written record of dates, because a pathway that has quietly stalled is far easier to challenge with one. [1] Where the delay is affecting your health, contact your GP rather than waiting for the next scheduled letter — this page covers access and cost, not clinical advice, and clinical questions belong with a clinician.
Going privately does not remove you from NHS care, and the two can run alongside each other, though the same episode cannot be split between them. Complaints about NHS waiting belong with the hospital’s patient advice and liaison service and then the parliamentary health service ombudsman; complaints about an insurer’s handling of a claim belong with the insurer and then the Financial Ombudsman Service. [5] If you are paying for treatment yourself, the published information about hospitals and consultants is the place to compare where you might be treated. [8]
Looking at cover with PremierPMI
PremierPMI is a specialist private medical insurance broker and the publisher of The Health Guide. If you want to talk through what this means for your own cover, you can start there.
Or, if you would rather start here, send an enquiry and PremierPMI will contact you.
Common questions
What happens if my 18-week wait is exceeded?
Is the NHS currently meeting the 18-week standard?
Does private health insurance shorten my NHS wait?
When exactly does the 18-week clock start?
Does a first appointment stop the clock?
Does the standard apply to cancer or emergency care?
Can I choose which hospital treats me?
Should I pay for treatment myself instead of waiting?
Sources and methodology
- [1] Department of Health and Social Care. “The NHS Constitution for England”. View source(opens in a new tab)Primary source
- [2] NHS. “Guide to NHS waiting times in England”. View source(opens in a new tab)Primary source
- [3] NHS England. “Referral to treatment (RTT) waiting times statistics, July 2026 data”. View source(opens in a new tab)Primary source
- [4] Financial Conduct Authority. “The Financial Services Register”. View source(opens in a new tab)Primary source
- [5] Financial Ombudsman Service. “Complaints about medical insurance”. View source(opens in a new tab)Primary source
- [6] Association of British Insurers. “Insurers process record £4bn across individual and workplace health schemes (2024 data)”. View source(opens in a new tab)Primary source
- [7] Private Healthcare Information Network. “Information about private hospitals and consultants”. View source(opens in a new tab)Primary source
- [8] Competition and Markets Authority. “Private healthcare market investigation”. View source(opens in a new tab)Primary source
We cite primary sources wherever possible. Read about our sourcing methodology.
Dior Teshayev
Health Insurance Editor, PremierPMI
- Health insurance editor
- Insurer product and literature research
Dior works alongside senior advisers to research and refine content about private medical insurance, producing articles, guides and updates that reflect the latest market and product changes. He tracks market trends, reviews insurer literature and prepares plain-English summaries for the advisory team.
Read full profile
Emma Leadbetter
Editor and Copywriter, PremierPMI
- 15 years health, finance and consumer journalism
- PhD candidate, University of Chichester
Emma has written across health, finance and consumer-affairs journalism for more than 15 years, and has been part of the PremierPMI team since 2022. She is known for making complex topics easy to understand, and fact-checks every guide against current insurer wording before it goes live. She is completing a PhD at the University of Chichester researching how the NHS has changed since COVID-19.
Read full profile
